U.S. COVID-19 Vaccination Program : vaccine channel portfolio by jurisdiction
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

U.S. COVID-19 Vaccination Program : vaccine channel portfolio by jurisdiction

Filetype[PDF-160.22 KB]


English
Details Supporting Files You May Also Like

Details:

  • Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
  • Description:
    Updated May 9, 2021

    This report provides an overview of the multiple channels being used to ensure all Americans have access to COVID-19 vaccine. Jurisdictional delivery and administration portfolios vary across the United States because of population variability.

    Vaccine administration data for the federal programs are reported to jurisdictions’ Immunization Information Services, but they cannot always be separated from administration data for jurisdictional vaccination programs. In some instances, provider type identifiers are missing and/or providers use inventory from both jurisdictional and federal allocations. Therefore, administration data for federal programs is presented in aggregate with jurisdictional totals. Federal entities report their administration data directly to CDC, so this category is listed separately.

    Administration ratios are provided to assess how well delivered doses of vaccine are being administered. These are important metrics to track, as they ensure the nation’s vaccine inventory is being used efficiently; however, they have limitations. First, comparing jurisdictions without considering the unique characteristics of each (for example, rural states vs. states with large urban centers) can lead to inaccurate conclusions. Further, jurisdictions and the federal government are striving to make vaccine accessible to all segments of the population, including those who have historically experienced barriers to critical healthcare-related services. Efforts to reach these populations that have been underserved might affect administration ratios but are necessary to ensure equitable vaccine distribution and administration.

  • Subjects:
  • Document Type:
    Webpage
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

You May Also Like

Checkout today's featured content at stacks.cdc.gov